Correlation Between Institute and Enzolytics
Can any of the company-specific risk be diversified away by investing in both Institute and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Institute and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Institute of Biomedical and Enzolytics, you can compare the effects of market volatilities on Institute and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Institute with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Institute and Enzolytics.
Diversification Opportunities for Institute and Enzolytics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Institute and Enzolytics is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Institute of Biomedical and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Institute of Biomedical are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of Institute i.e., Institute and Enzolytics go up and down completely randomly.
Pair Corralation between Institute and Enzolytics
Given the investment horizon of 90 days Institute of Biomedical is expected to generate 2.29 times more return on investment than Enzolytics. However, Institute is 2.29 times more volatile than Enzolytics. It trades about 0.26 of its potential returns per unit of risk. Enzolytics is currently generating about -0.25 per unit of risk. If you would invest 0.42 in Institute of Biomedical on September 2, 2024 and sell it today you would earn a total of 0.53 from holding Institute of Biomedical or generate 126.19% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Institute of Biomedical vs. Enzolytics
Performance |
Timeline |
Institute of Biomedical |
Enzolytics |
Institute and Enzolytics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Institute and Enzolytics
The main advantage of trading using opposite Institute and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Institute position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.Institute vs. Rigel Pharmaceuticals | Institute vs. Geron | Institute vs. Verastem | Institute vs. Immutep Ltd ADR |
Enzolytics vs. Creative Medical Technology | Enzolytics vs. Regen BioPharma | Enzolytics vs. Therasense | Enzolytics vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Correlations Find global opportunities by holding instruments from different markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |